Fresenius Medical Care AG (FME.DE)

35,82 -0,61 (-1,67%) A partir del 02:06PM CEST. Mercado abierto.

Fresenius Medical Care AG

Else-KrOener-Strasse 1
Bad Homburg 61352
Germany
49 6172 609 0
https://www.freseniusmedicalcare.com

Sector(es): Healthcare
Sector: Medical Care Facilities
Empleados a tiempo completo: 119.845

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Ms. Helen Giza	CEO & Chair of Management Board of Fresenius Med. Care Mgmt AG	4,93M	N/A	1968
Mr. Martin Fischer	CFO & Member of the Management Board of Fresenius Medical Care Management AG	887k	N/A	1977
Dr. Franklin W. Maddux F.A.C.P.	Global Chief Medical Officer & Member of Management Board of Fresenius Medical Care Management AG	2,77M	N/A	1957
Dr. Katarzyna Mazur-Hofsab Ph.D.	Management Board Member for Care Enablement of Fresenius Medical Care Management AG	2,88M	N/A	1963
Mr. Craig Cordola FACHE, M.B.A., M.H.A.	CEO of Care Delivery & Member of Management Board	N/A	N/A	1970
Dr. Dominik Heger	Executive VP and Head of Investor Relations, Strategic Development & Communications	N/A	N/A	N/A
Mr. Joachim Weith	Senior Vice President of Corporate Communications & Governmental Affairs	N/A	N/A	N/A
Dr. Gail-Suzanne Brown	Senior Vice President of Research & Development	N/A	N/A	N/A
Mr. Glenn Slater	Senior Vice President of Manufacturing and Supply Chain Operations	N/A	N/A	N/A
Dr. Wolfgang Kummerle	Senior Vice President - Quality Management International	N/A	N/A	N/A

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en EUR.

Descripción

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Gobierno corporativo

El ISS Governance QualityScore de Fresenius Medical Care AG, a día 1 de abril de 2024, es 8. Las puntuaciones base son Auditoría: 3; Tablero: 7; Derechos de los accionistas: 1; Compensación: 9.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.